RESUMO
A retrospective analysis was conducted on 20 D(-) liver transplant (LT) recipients transfused with D(+) RBCs perioperatively and screened for RBC antibodies between 2 and 6 months later. None developed anti-D detectable by the indirect antiglobulin test. Two patients produced weak anti-D that reacted only with papain-treated RBCs at 10 and 11 days without any sign of immune haemolysis. Antibodies became quickly undetectable. These data suggest an unusual pattern of alloimmunization in LT recipients with rapid, weak and transient antibody response and support the safety of transfusing D(+) RBCs in most of D(-) patients during LT surgery.
Assuntos
Teste de Coombs , Transplante de Fígado , Imunoglobulina rho(D)/sangue , Adulto , Transfusão de Sangue , Eritrócitos/citologia , Eritrócitos/imunologia , Eritrócitos/metabolismo , Feminino , Hemólise , Humanos , Isoanticorpos/sangue , Masculino , Pessoa de Meia-Idade , Papaína/metabolismo , Estudos Retrospectivos , Imunoglobulina rho(D)/imunologia , Adulto JovemRESUMO
A 23-year-old female with polymyositis received high dose intravenous immunoglobulin (IVIg) therapy. The patient suffered severe hemolytic anemia after receiving first course of IVIg infusion. This adverse reaction was likely due to allohemaglutinin A and B and from or high molecular weight IgG complexes contained in the preparation. Though this effect was observed, the treatment was repeated six times. A mild hemolysis occurred following each IVIg, with no clinical consequence. Involvement of the saturation of macrophagic receptors might explain this partial destruction of erythrocytes.
Assuntos
Anemia Hemolítica/etiologia , Imunoglobulinas Intravenosas/uso terapêutico , Polimiosite/complicações , Polimiosite/terapia , Adesinas Bacterianas , Adulto , Proteínas de Bactérias/imunologia , Contraindicações , Feminino , Hemaglutininas/imunologia , Humanos , Imunoglobulina G/imunologia , Imunoglobulinas Intravenosas/efeitos adversos , Lectinas , RecidivaRESUMO
Blood transfusion is mainly bound to immunological and infectious risks. The immunological risk originates from an incompatibility between the blood of the donor and that of the recipient; this risk remains insufficiently assessed. A multicentre study has been carried out by the French Blood Transfusion Society and the National Institute for Blood Transfusion. Sixty-one accidents due to an erythrocyte incompatibility were found: 26 cases with ABO incompatibility, and 35 cases with alloantibodies of other blood group systems. For the former category of accidents, the most frequent cause was due to a failure in the realization of the bedside ABO check. For the latter, the main problem was the achievement and the interpretation of antibody screening. The long term follow-up shows no chronic after-effects of immunological accidents. For each accident, errors have been identified and analysed. It was proven that they all originate from health care establishments.